$16.83
0.03 (+0.18%)
Cubist Pharmaceuticals, Inc. (CBST)
CAPS Rating:
A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

RSS Headlines
Fool UK